Cargando…
Engineering antibody and protein therapeutics to cross the blood–brain barrier
Diseases in the central nervous system (CNS) are often difficult to treat. Antibody- and protein-based therapeutics hold huge promises in CNS disease treatment. However, proteins are restricted from entering the CNS by the blood–brain barrier (BBB). To achieve enhanced BBB crossing, antibody-based c...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759110/ https://www.ncbi.nlm.nih.gov/pubmed/36540309 http://dx.doi.org/10.1093/abt/tbac028 |